Biocytogen Boston Corp
Leveraging proprietary, high-efficiency gene-editing technologies, Biocytogen is a global leader in animal and cell model generation for preclinical research. Through BioMice™, we offer thousands of off-the-shelf drug-targeted humanized models, providing ready-to-use solutions for drug efficacy, safety, and mechanistic studies. Beyond model generation, Biocytogen accelerates global drug discovery with comprehensive preclinical pharmacology and gene-editing services, driving breakthroughs in oncology, immunology, and beyond.
